Cross-reactivities between chemically induced rat tumors and fetal tissues were examined by the migration inhibition test. Wistar/Fib adult rats were immunized by intracutaneous injection of Freund incomplete adjuvant with or without the extracts of various fetal tissues (one-week whole fetal tissue, two-week fetus without brain and spinal cord, and two-week fetal brain). A mixture of thymic and lymph-node cells was used as migration cells. Peripheral neurinomas (T1 and T3) and oligodendroglioma (T2) were induced by ethylnitrosourea with single intraperitoneal injection in pregnant rats in the third week of gestation; 3M KCl extracts of these tumors served as antigens. The animals sensitized by two-week fetus reacted with all neurogenic tumors although in half of them (4/8) no significant differences from the reaction of the lymphoid cells sensitized by Freund incomplete adjuvant alone were demonstrated. The lymphoid cells sensitized by one-week fetus showed the weakest responses (especially in the reaction with T3 tumor) among all fetal extracts.
Introduction
There are several antigens on the surface of tumor cell membranes, such as histocompati bility, tumor specific, transplantation, fetal and widespread tumor antigens.
When tumors have common surface features, such features are quite useful for both diagnosis and treatment.
It is a well known fact that virally induced tumors and many spontaneous animal tumors (murine and feline) have common surface antigens. However, there are still many conflicting opinions about chemically induced animal tumors.
In our preliminary experiment,15) cross reactivities between ethyl nitrosourea (ENU) induced rat neurogenic tumors and fetal tissues were suggested.
In the present study, the migration inhibition test (MIT) was performed to clarify these carcino-fetal antigenicities.
Materials and Methods
Two-month-old male Wistar/Fib rats fed under `minimum disease' conditions in the Fibiger laboratory were immunized by the injection of 250 ug of 3M KCl extracts of several fetal tissues (such as one-week whole fetus, two week fetus without brain and spinal cord, and two-week fetal brain) with 15 ul of Freund incomplete adjuvant. For the control sensitiza tion, rats were injected with Freund incomplete adjuvant alone in the same schedule.
Sensitization was performed by four intra cutaneous injections on both flanks of rats at weekly intervals. Between seven and ten days after the final injection, rats were sacrificed under ether anesthesia and thymic and lymph node cells (inguinal, axillar, brachial, sub mandibular, and parathymic) were collected.
The MIT was performed with these lymphoid cells as reported previously 15) with the minor modification of TC 199 plus 10% FCS as the migration medium. Hexaplicated plates were prepared in each group and the results were calculated by two-tailed Student's t-tests. P values of less than 5% were considered as positive results.
Three molar KCl extracts of ENU induced rat neurogenic tumors 14) were prepared from the tumor block of the first transplant genera tion which had been kept frozen at -80'C until use. A final dilution of the extracts of 50 pg/ml protein was used as the antigens. Two-week fetal brain reacted with T1 tumor more strongly than with T2 or T3 tumors (Table 2 ). This might be explained by the presence of a high titer of brain specific antigens in T1 tumor, as shown in our previous paper'5 and also reported by other authors.")
In Table 3 , the results of lymphoid cells sensitized by one-week fetus are shown. These responses were somewhat weaker than those of the other two extracts from two-week fetus; in particular, none of the T3 extracts showed positive results.
The results of MIT of lymph-node cells without thymic cells was also determined (Tables 4 and 5 ). Unexpectedly, no positive results were obtained in these experiments, although some immunological responses in MIT with lymph-node cells alone had been previously confirmed in a murine system.' 3)
The lymph-node cells sensitized by one-week fetus showed significantly positive reactions to all tumor extracts (Table 6 ), in contrast with the mixed thymic and lymph-node cells as described above. In in vitro systems, many tumors have proven to show a common reactivity to fetal tissues. These include methylchoranthrene in duced sarcomas,',",") SV-40 induced sar coma,7 and dimethylaminoazobenzene induced hepatoma,2) in various species of animals such as mice, rats, and guinea pigs. Chism5) strongly insisted that all tumors have fetal antigens.
However, most of the animal studies tested in vivo failed to demonstrate the rejection of tumor cells from the embryonic immunized recipients, even when the presence of fetal antigens on tumor cells was suggested since the tumors were rarely accepted by the multiparous animals9,11> and/or newborn animals22> which were thought to preserve the rest of the fetal antigens.
Shah19) obtained negative results in the active protection test, but positive results in the tumor neutralization test. However, fetal antigens can, in some instances, function as transplantation antigens and induce weak tumor resistance. In the system where fetal tissue immunization is ineffective against tumor growth, in spite of in vitro evidence of fetal antigen expression by tumor, the expressed fetal antigens such as the TL antigen') or Gross cell-surface antigen,l " may not be able to function as transplantation antigens or they may be modulated in vivo.
The discrepancies between in vivo and in vitro reactions of tumor and fetal tissues might be explained as follows: 1) There may be genetically determined differences in the capa bility of different species to respond immunol ogically to fetal-tissue antigen.20) 2) Expression of fetal antigens may differ quantitatively in various tumors. 3) Tumor cell fetal antigen may be modulated in vivo as indicated in Rauscher virus-induced leukemia. 16) 4) The route and schedules of immunization may change the responsibility of tumor rejection. 5) There may be slight differences in the expres sion of fetal antigen depending on the type of fetal tissues used for immunization.3)
In our experiments, all three neurogenic tumors were found to react with fetal extracts to some degree. Salinas 18> found the strongest expression of fetal antigen at 15 days of gesta tion in mice using a mineral oil induced plasma cell ascites tumor. The rat shows the same tendencies.') The period is at 9-10 days in hamsters,6) and about 19 weeks in humans. 18) In contrast, Ishimoto1" stated that in mice fetal antigens appear at 12 days of gestation and continue until birth.
In our study, the two-week fetus reacted most strongly. Moreover, in our most recent experiment, which will be reported later, we have found that the expression of the fetal antigens of three-week fetus is less than that of two-week fetus. For this reason, we have an opinion similar to that of Salinas.
The strength of the expression of T 1 and T3 tumors is not well correlated with our previous results.") This might be due to the antigenic modulation in vivo as noted by Gotohda et al.8)
In our experience with MIT using various lymphoid cells, spleen cells did not give reproducible results. Migration faculties are best in the thymic cells although the immuno logic responses in thymic cells are thought to be nearly the same or slightly better than those in lymph-node cells.") Therefore, a mixture of thymic and lymph-node cells was generally used in our experiments. The discrepancy between the results of this mixture and those of lymph node cells alone can most likely be explained by the reason mentioned above. However, the distinctive positive reaction with one-week fetus sensitized lymph-node cells (as shown in Table 6 ) is difficult to explain. A possible explanation is that the fetal cells in the early stage have specially reacting sites with lymph node cells and not with thymocytes, and these reactions might be exacerbated by adjuvant stimulation.
The present study and other determinations of the effectiveness of fetal antigens in the responses with various tumor cells, both in vivo and in vitro. All these mechanisms need to be extensively studied and evaluated. 
